Group,Seq,Gene,Description,Chromosome,Size [bp]
1.1,1,ADRA1A,Alpha-1A-adrenergic receptor Norepinephrine Receptor,8p21.2,117256
1.1,2,ADRA1B,Alpha-1B-adrenergic receptor Norepinephrine Receptor,5q33.3,55762
1.1,3,ADRA1D,Alpha-1D-adrenergic receptor Norepinephrine Receptor,20p13,27844
1.1,4,ADRA2A,Alpha-2A-adrenergic receptor Norepinephrine Receptor,10q25.2,3650
1.1,5,ADRA2B,Alpha-2B-adrenergic receptor Norepinephrine Receptor,2q11.2,3266
1.1,6,ADRA2C,Alpha-2C-adrenergic receptor Norepinephrine Receptor,4p16,2819
1.1,7,ADRB1,Beta-1-adrenergic receptor Norepinephrine Receptor,10q25.3,1714
1.1,8,QDPR,Quinoid dihydropteridine reductase 5-HT Metabolic enzyme,4p15.32,25691
1.1,9,TPH1,Tryptophan hydroxylase 1 5-HT Metabolic enzyme, 11p15.1,19772
1.1,10,TPH2,Tryptophan hydroxylase 2 5-HT Metabolic enzyme, 12q15,93595
1.1,11,HTR1A,5-Hydroxytryptamine (serotonin) receptor 1A 5-HT Receptor, 5q12.3,1269
1.1,12,HTR1B,5-Hydroxytryptamine (serotonin) receptor 1B 5-HT Receptor, 6q14.1,1173
1.1,13,HTR1D,5-Hydroxytryptamine (serotonin) receptor 1D 5-HT Receptor, 1p36.12,2835
1.1,14,HTR1E,5-Hydroxytryptamine (serotonin) receptor 1E 5-HT Receptor, 6q15,78988
1.1,15,HTR1F,5-Hydroxytryptamine (serotonin) receptor 1F 5-HT Receptor, 3q11.1,1101
1.1,16,HTR2A,5-Hydroxytryptamine (serotonin) receptor 2A 5-HT Receptor, 13q14.2,62661
1.1,17,HTR2B,5-Hydroxytryptamine (serotonin) receptor 2B 5-HT Receptor, 2q37.1,15587
1.1,18,HTR2C,5-Hydroxytryptamine (serotonin) receptor 2C 5-HT Receptor, Xq23,326074
1.1,19,HTR3A,5-Hydroxytryptamine (serotonin) receptor 3A 5-HT Receptor, 11q23.2,15195
1.1,20,HTR3B,5-Hydroxytryptamine (serotonin) receptor 3B 5-HT Receptor, 11q23.2,41378
1.1,21,HTR4,5-Hydroxytryptamine (serotonin) receptor 4 5-HT Receptor, 5q32,172618
1.1,22,HTR5A,5-Hydroxytryptamine (serotonin) receptor 5A 5-HT Receptor, 7q36.2,13583
1.1,23,HTR6,5-Hydroxytryptamine (serotonin) receptor 6 5-HT Receptor, 1p36.13,14276
1.1,24,HTR7,5-Hydroxytryptamine (serotonin) receptor 7 5-HT Receptor, 10q23.31,115268
1.1,25,SLC6A4,"Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 HTT SERT 5-HT Transporter", 17q11.2,24118
1.1,26,ABCG1,ATP-binding cassette subfamily G member 1 5-HT Others, 21q22.3,77974
1.1,27,DBH,Dopamine beta-hydroxylase precursor Dopamine Metabolic enzyme, 9q34.2,22982
1.1,28,DRD1,D1 dopamine receptor Dopamine Receptor, 5q35.2,3127
1.1,29,DRD2,D2 dopamine receptor Dopamine Receptor, 11q23.2,65577
1.1,30,DRD3,D3 dopamine receptor Dopamine Receptor, 3q13.31,50200
1.1,31,DRD4,D4 dopamine receptor Dopamine Receptor, 11p15.5,3400
1.1,32,DRD5,D5 dopamine receptor Dopamine Receptor, 4p16.1,2032
1.1,33,NR4A2,"Nuclear receptor subfamily 4, group A, member 2 NURR1 Dopamine Others", 2q24.1,8250
1.1,34,DDC,DOPA decarboxylase Multiple monoaminergic systems Metabolic enzyme, 7p12.2,102610
1.1,35,MAOA,Monoamine oxidase A Multiple monoaminergic systems Metabolic enzyme, Xp11.3,70206
1.1,36,MAOB,Monoamine oxidase B Multiple monoaminergic systems Metabolic enzyme, Xp11.3,115765
1.1,37,TH,Tyrosine hydroxylase Multiple monoaminergic systems Metabolic enzyme, 11p15.5,7887
1.1,38,COMT,Catechol-O-methyltransferase Multiple monoaminergic systems Metabolic enzyme, 22q11,27047
1.1,39,SLC6A2,"Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 NET Multiple monoaminergic systems Transporter", 16q12.2,46031
1.1,40,SLC6A3,"Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 DAT Multiple monoaminergic systems Transporter", 5p15.33,52637
1.1,41,SLC18A1,"Solute carrier family 18 (vesicular monoamine), member1 VMAT1 Multiple monoaminergic systems Vesicular transporter", 8p21.3,38346
1.1,42,SLC18A2,"Solute carrier family 18 (vesicular monoamine), member2 VMAT2 Multiple monoaminergic systems Vesicular transporter", 10q26.11,36203
1.2,1,CHAT,Choline acetyltransferase Metabolic enzyme, 10q11.23,56010
1.2,2,CHRNA3,"Cholinergic receptor, nicotinic, alpha polypeptide 3 Receptor", 15q24.3,25679
1.2,3,CHRNA4,"Cholinergic receptor, nicotinic, alpha polypeptide 4 Receptor", 20q13.33,16298
1.2,4,CHRNA5,"Cholinergic receptor, nicotinic, alpha polypeptide 5 Receptor", 15q24.3,27806
1.2,5,CHRNA6,"Cholinergic receptor, nicotinic, alpha polypeptide 6 Receptor", 8p11.21,15857
1.2,6,CHRNA7,"Cholinergic receptor, nicotinic, alpha polypeptide 7 Receptor", 15q13.3,184762
1.2,7,CHRNB2,"Cholinergic receptor, nicotinic, beta polypeptide 2 Receptor", 1q22,8827
1.2,8,CHRNB3,"Cholinergic receptor, nicotinic, beta polypeptide 3 Receptor", 8p11.21,39290
1.2,9,CHRM1,"Cholinergic receptor, muscarinic 1 Receptor", 11q12.3,1383
1.2,10,CHRM2,"Cholinergic receptor, muscarinic 2 Receptor", 7q33,1401
1.2,11,CHRM4,"Cholinergic receptor, muscarinic 4 Receptor", 11p11.2,1455
1.3,1,GABRA1,"Gamma-aminobutyric acid (GABA) A receptor, alpha 1; GABA", 5q34,50180
1.3,2,GABRA2,"Gamma-aminobutyric acid A receptor, alpha 2 GABA Receptor", 4p12,140186
1.3,3,GABRA3,"Gamma-aminobutyric acid A receptor, alpha 3 GABA Receptor", Xq28,283210
1.3,4,GABRA5,"Gamma-aminobutyric acid A receptor, alpha 5 GABA Receptor", 15q12,34408
1.3,5,GABBR1,Gamma-aminobutyric acid B receptor 1 GABA Receptor, 6p22.1,30856
1.3,6,SLC6A1,"Solute carrier family 6 (neurotransmitter transporter, GABA), member 1 GABA Transporter", 3p25.3,21553
1.3,7,SLC6A11,"Solute carrier family 6 (neurotransmitter transporter, GABA), member 11 GAT1 GABA Transporter", 3p25.3,122230
1.3,8,SLC6A12,"Solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 BGT1 GABA Transporter", 12p13.33,23241
1.3,9,VIAAT,Vesicular inhibitory amino-acid transporter GABA Transporter, 20q11.23,4887
1.3,10,DBI,"Diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein) GABA Others", 2q14.2,4975
1.3,11,GAD2,Glutamate decarboxylase 2 GAD65 Glutamate GABA Metabolic enzyme, 10p12.1,87894
1.3,12,GAD1,Glutamate decarboxylase 1 GAD67 Glutamate GABA Metabolic enzyme ,2q31.1,25848
1.3,13,ABAT,4-Aminobutyrate aminotransferase precursor GABA-T Glutamate GABA Metabolic enzyme, 16p13.2,109987
1.3,14,GLRA3,"Glycine receptor, alpha 3 Glutamate Receptor", 4q34.1,186168
1.3,15,GLRB,"Glycine receptor, beta Glutamate Receptor", 4q32.1,95517
1.3,16,GRIA1,"Glutamate receptor, ionotropic, AMPA 1 Glutamate Receptor", 5q33.2,364262
1.3,17,GRIA2,"Glutamate receptor, ionotropic, AMPA 2 Glutamate Receptor", 4q32.1,143068
1.3,18,GRIA3,"Glutamate receptor, ionotropic, AMPA 3 Glutamate Receptor", Xq25,304502
1.3,19,GRIA4,"Glutamate receptor, ionotrophic Glutamate Receptor", 11q22.3,368731
1.3,20,GRIK1,"Glutamate receptor, ionotropic kainate 1 Glutamate Receptor", 21q21.3,402421
1.3,21,GRIK2,"Glutamate receptor, ionotropic kainate 2 Glutamate Receptor", 6q16.3,669205
1.3,22,GRIK3,"Glutamate receptor, ionotropic kainate 3 Glutamate Receptor", 1p34.3 ,233113
1.3,23,GRIK4,"Glutamate receptor, ionotropic kainate 4 Glutamate Receptor", 11q23.3 ,325942
1.3,24,GRIK5,"Glutamate receptor, ionotropic kainate 5 Glutamate Receptor", 19q32.2 ,64020
1.3,25,GRIN1,N-methyl-D-aspartate receptor subunit zeta 1 (precursor) Glutamate Receptor, 9q34.3,28919
1.3,26,GRIN2A,N-methyl-D-aspartate receptor subunit 2A Glutamate Receptor, 16p13.2,421920
1.3,27,GRIN2B,N-methyl-D-aspartate receptor subunit 2B Glutamate Receptor ,12q13.1,418909
1.3,28,GRIN2C,N-methyl-D-aspartate receptor subunit 2C Glutamate Receptor, 17q25.1,18802
1.3,29,GRIN2D,N-methyl-D-aspartate receptor subunit 2D Glutamate Receptor, 19q13.33,49262
1.3,30,GRM1,"Glutamate receptor, metabotropic 1 Glutamate Receptor", 6q24.3,408316
1.3,31,GRM2,"Glutamate receptor, metabotropic 2 precursor Glutamate Receptor", 3p21.31,9131
1.3,32,GRM3,"Glutamate receptor, metabotropic 3 precursor Glutamate Receptor", 7q21.12,220113
1.3,33,GRM4,Metabotropic glutamate receptor 4 Glutamate Receptor, 6p21.31,111816
1.3,34,GRM5,"Glutamate receptor, metabotropic 5 Glutamate Receptor ",11q14.3,540352
1.3,35,GRM6,"Glutamate receptor, metabotropic 6 precursor Glutamate Receptor", 5q35.3,16793
1.3,36,GRM7,"Glutamate receptor, metabotropic 7 Glutamate Receptor ",3p26.1,880272
1.3,37,GRM8,Metabotropic glutamate receptor 8 precursor Glutamate Receptor, 7q31.33,804658
1.3,38,SLC1A1,"Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 EAAT3 Glutamate Transporter", 9p24.2,96815
1.3,39,SLC1A2,"Solute carrier family 1 (glial high-affinity glutamate transporter), member 2 EAAT2 Glutamate Transporter", 11p13,158150
1.3,40,SLC1A3,"Solute carrier family 1 (glial high-affinity glutamate transporter), member 3 EAAT1 Glutamate Transporter", 5p13.2,81750
1.3,41,SLC1A6,"Solute carrier family 1 (high-affinity aspartate/glutamate transporter), member 6 EAAT4 Glutamate Transporter", 19p13.12,22740
1.3,42,SLC6A9,"Solute carrier family 6 neurotransmitter transporter, glycine), member 9 GLYT1 Glutamate Transporter", 1p34.1,25587
1.3,43,DAO,D-amino-acid oxidase Glutamate Metabolic enzyme ,12q24.11,20831
1.3,44,SRR,Serine racemase Glutamate Metabolic enzyme, 17p13.3,21306
1.4,1,AVP,Arginine vasopressin neurophysin II Peptide Transporter, 20p13,2873
1.4,2,AVPR1A,Arginine vasopressin receptor 1A Peptide Recepto,r 12q14.2,6375
1.4,3,CCK,"Cholecystokinin Peptide Neurotransmitter, Intercellular signaling", 3p22.1,6802
1.4,4,CCKAR,Cholecystokinin A receptor Peptide Receptor, 4p15.2,9025
1.4,5,CCKBR,Cholecystokinin B receptor Peptide Receptor, 11p15.4,12202
1.4,6,HCRT,"Orexin precursor Peptide Neurotransmitter, Intercellular signaling",17q21.2,1393
1.4,7,HCRTR1,Orexin receptor 1 Peptide Receptor, 1p35.2,8074
1.4,8,HCRTR2,Orexin receptor 2 Peptide Receptor, 6p12.1,108347
1.4,9,NPY,"Neuropeptide Y Peptide Neurotransmitter, Intercellular signaling ", 7p15.3,417168
1.4,10,NPY1R,Neuropeptide Y receptor Y1 Peptide Receptor, 4q32.2,2797
1.4,11,NPY2R,Neuropeptide Y receptor Y2 Peptide Receptor, 4q32,1152
1.4,12,NPY5R,Neuropeptide Y receptor Y5 Peptide Receptor, 4q32,4165
1.4,13,NTS,Neurotensin Peptide Neurotransmitter; Intercellular signaling , 12q21.31,8689
1.4,14,NTSR1,Neurotensin receptor 1 Peptide Receptor, 20q13.33,53934
1.4,15,NTSR2,Neurotensin receptor 2 Peptide Receptor, 2p25.1,12121
1.4,16,SST,Somatostatin Peptide Neurotransmitter; Intercellular signaling  , 3q27.3,1227
1.4,17,TAC1,"Tachykinin, precursor 1 Peptide Neurotransmitter; Intercellular signaling ", 7q21.3,8408
1.4,18,TACR1,Tachykinin receptor 1 Peptide Receptor, 2p12,150044
1.4,19,TACR2,Tachykinins receptor 2 Peptide Receptor, 10q22.1,11498
1.4,20,TACR3,Tachykinins receptor 3 Peptide Receptor, 4q24,130349
1.4,21,VIP,Vasoactive intestinal peptide Peptide Neurotransmitter; Intercellular signaling  , 6q25.2,8857
1.4,22,VIPR2,Vasoactive intestinal peptide receptor 2 VPAC2 Peptide Receptor, 7q36.3,116783
1.4,23,PMCH,Pro-melanin-concentrating hormone Peptide Neurotransmitter; Intercellular signaling  , 12q23.2,1364
1.4,24,GPR24,G-protein-coupled receptor 24 MCHR1 Peptide Receptor, 22q13.2,3582
1.4,25,PDYN,Beta-neoendorphin-dynorphin preproprotein Peptide Neurotransmitter; Intercellular signaling    , 20p13,15300
1.4,26,OPRD1,"Opioid receptor, delta1 Opioid Receptor", 1p35.3,51552
1.4,27,OPRK1,"Opioid receptor, kappa1 Opioid Receptor", 8q11.23,21771
1.4,28,OPRM1,"Opioid receptor, kappa1 Opioid Receptor", 6q25.2,80118
1.4,29,ADORA1,Adenosine A1 receptor Others Receptor ,1q32.1,76750
1.4,30,ADORA2A,Adenosine A2a receptor Others Receptor, 22q11.23,9234
1.4,31,ADORA2B,Adenosine A2b receptor Others Receptor, 17p12,30980
1.4,32,ADORA3,Adenosine receptor A3 Others Receptor, 1p13.2,4689
2.1,1,POMC,Proopiomelanocortin ACTH Neurotransmitter; Intercellular signaling , 2q23.3,7665
2.1,2,CRH,Corticotropin-releasing hormone precursor NeurotransmitterIntercellular signaling , 8q13.1,2080
2.1,3,CRHR1,Corticotropin-releasing hormone receptor 1 Receptor, 17q21.31,51525
2.1,4,CRHR2,Corticotropin-releasing hormone receptor 2 Receptor, 7p14.3,29697
2.1,5,MC2R,Melanocortin 2 receptor (adrenocorticotropic hormone) Receptor ,18p11.21,894
2.1,6,NR3C1,"Nuclear receptor subfamily 3, group C, member 1 (Glucocorticoid receptor) Receptor", 5q31.3,123763
2.1,7,NR3C2,"Nuclear receptor subfamily 3, group C, member 2 (Mineralocorticoid receptor) Receptor", 4q31.23,363604
2.1,8,MC4R,Melanocortin 4 receptor Receptor, 18q21.32,999
2.1,9,HSPA5,"Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa); GRP78", 9q33.3,6478
2.1,10,SERPINA6,Corticosteroid binding globulin precursor CBG Others, 14q32.13, 19 088
2.1,11,ABCB1,ATP-binding cassette subfamily B member 1 ABCB1 Others ,7q21.12,209617
2.1,12,HSD11B1,11-Beta-hydroxysteroid dehydrogenase 1 Enzyme,,48746
2.2,1,BDNF,Brain-derived neurotrophic factor Neurotransmitter; Intercellular signaling,11p14.1,63295
2.2,2,EGF,Epidermal growth factor Neurotransmitter; Intercellular signaling, 4q25,99370
2.2,3,FGF2,Fibroblast growth factor2 Neurotransmitter; Intercellular signaling, 4q27,71528
2.2,4,IGF1,Insulin-like growth factor I Neurotransmitter; Intercellular signaling, 12q23.2,84649
2.2,5,TGFB1,"Transforming growth factor, beta 1 Neurotransmitter; Intercellular signaling", 19q13.2,23561
2.2,6,IGF1R,Insulin-like growth factor 1 receptor precursor Receptor, 15q26.3,308747
2.2,7,NTRK2,"Neurotrophic tyrosine kinase, receptor, type 2 TrkB Receptor", 9q21.33,352717
2.2,8,NTRK3,Neurotrophin receptor 3 Receptor, 15q25.3,379607
3,1,ADCY2,Adenylate cyclase 2 cAMP signaling, 5p15.31,433850
3,2,ADCY9,Adenylate cyclase 9 cAMP signaling, 16p13.3,150555
3,3,ADRBK2,Beta adrenergic receptor kinase 2 GRK3 cAMP signaling, 22q12.1,158971
3,4,CREB1,CAMP-responsive element binding protein 1 cAMP signaling, 2q33.3,68897
3,5,CREM,CAMP-responsive element modulator cAMP signaling, 10p11.21,84983
3,6,GNAI2,Guanine nucleotide binding protein cAMP signaling, 3p21.31,22633
3,7,GNAL,"Guanine nucleotide binding protein (G protein), alpha-activating activity polypeptide, olfactory type cAMP signaling", 18p11.21,129640
3,8,GNAS,"Guanine nucleotide binding protein (G protein), alpha-stimulating activity polypeptide 1 (LL) cAMP signaling", 20q13.32,71451
3,9,PDE4A,"Phosphodiesterase 4A, cAMP-specific cAMP signaling", 19p13.2,47837
3,10,PDE4B,"Phosphodiesterase 4B, cAMP-specific cAMP signalin", 1p31.2,580324
3,11,PDE4D,"Phosphodiesterase 4D, cAMP-specific cAMP signaling", 5q11.2,615565
3,12,PRKACA,"Protein kinase, cAMP-dependent, catalytic, alpha cAMP signaling", 19p13.13,26045
3,13,PRKAR2B,"Protein kinase, cAMP-dependent, regulatory, type II, beta cAMP signaling", 7q22.3,116687
3,14,RGS20,Regulator of G-protein signaling 20 cAMP signaling, 8q11.23,78299
3,15,RGS4,Regulator of G-protein signaling 4 cAMP signaling, 1q23.3,5184
3,16,RGS7,Regulator of G-protein signaling 7 cAMP signaling, 1q43,581608
3,17,PPP1R1B,"Protein phosphatase 1, regulatory (inhibitor) subunit 1B DARPP-32 cAMP signaling Calcium signaling", 17q12,9699
3,18,PPP1R9B,Protein phosphatase 1 regulatory subunit 9B Spinophilin cAMP signaling; Calcium signaling, 17q21.33,15179
3,19,CAMK2A,Calcium/calmodulin-dependent protein kinase II alpha cAMP signaling; Calcium signaling, 5q33.1,70277
3,20,KCNN3,Calcium-activated potassium channel SK3 hSK3 Calcium signaling, 1q22,162714
3,21,MARCKS,Myristoylated alanine-rich protein kinase C Calcium signaling; Phosphoinositide, 6q21,4425
3,22,PRKCA,"Protein kinase C, alpha Calcium signaling; Phosphoinositide", 17q24.1,499979
3,23,PRKCE,"Protein kinase C, epsilon Calcium signaling; Phosphoinositide", 2p21,532811
3,24,PLA2G1B,"Phospholipase A2, group IB (pancreas) Calcium signaling; Phosphoinositide Neurotrophic factors", 12q24.31,5674
3,25,PLCG1,"Phospholipase C, gamma 1 Calcium signaling; Phosphoinositide Neurotrophic factors ", 20q12,38
3,26,GNB3,Guanine nucleotide-binding protein beta-3 Calcium signaling; cAMP signaling Phosphoinositide, 12p13.31,7183
3,27,BCL2,B-cell CLL/lymphoma 2 Neurotrophic factors, 18q21.33,195352
3,28,DUSP6,Dual-specificity phosphatase 6 Neurotrophic factors, 12q21.33,4023
3,29,MAP2K2,Mitogen-activated protein kinase kinase 2 Neurotrophic factors, 19p13.3,33805
3,30,MAPK1,Mitogen-activated protein kinase 1 Neurotrophic factors, 22q11.21,105092
3,31,AKT1,v-Akt murine thymoma viral oncogene homolog 1 Neurotrophic factors; Phosphoinositide, 14q32.33,23856
3,32,GNAQ,"Guanine nucleotide binding protein (G protein), q Phosphoinositde ",9q21.2,311000
3,33,GNA11,"Guanine nucleotide binding protein (G protein), alpha 11 (Gq class) Phosphoinositide", 19p13.3,26923
3,34,IMPA1,Inositol(myo)-1(or 4)-monophosphatase 1 Phosphoinositide, 8q21.13,28365
3,35,IMPA2,Inositol(myo)-1(or 4)-monophosphatase 2 Phosphoinositide ,18p11.21,49422
3,36,INPP5F,Inositol polyphosphate-5-phosphatase F Phosphoinositide ,10q26.12,103044
3,37,ITPKA,1D-Myo-inositol-trisphosphate 3-kinase A Phosphoinositide, 15q15.1,9624
3,38,ITPKB,"Inositol-1,4,5-triphosphate-3 kinase B Phosphoinositide", 1q42.12,104439
3,39,PIB5PA,"Phosphatidylinositol (4,5) bisphosphate Phosphoinositide ",22q12.2,11703
3,40,PIK3C2B,"Phosphoinositide-3-kinase, class 2, beta polypeptide Phosphoinositide ",1q32.1,67707
3,41,PIK3C3,"Phosphoinositide-3-kinase, class 3 Phosphoinositide", 18q12.3,126246
3,42,PIK4CA,"Phosphatidylinositol 4-kinase, catalytic, alpha peptide Phosphoinositide ",22q11.21,131028
3,43,PIP5K2A,Phosphatidylinositol-4-phosphate 5-kinase type Phosphoinositide ,10p12.2,177663
3,44,KIAA0274,Sac domain-containing inositol phosphatase 3 Phosphoinositide, 6q21,134167
3,45,SYNJ1,Synaptojanin 1 Phosphoinositide, 21q22.11,96978
4.1,1,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like; BMAL1,11p15.3 ,109433
4.1,2,ARNTL2,Transcription factor BMAL2, 12p11.23,87479
4.1,3,BHLHB2,Differentiated embryo chondrocyte expressed gene 1-Dec, 3p26.1,5654
4.1,4,aBHLHB3,"Basic helix loop helix domain containing, class B, 3 2-Dec", 12p12.1,4886
4.1,5,CLOCK,Clock, 4q12,114338
4.1,6,CRY1,Cryptochrome 1 (photolyase-like), 12q23.3,102181
4.1,7,CRY2,Cryptochrome 2 (photolyase-like), 11p11.2,35768
4.1,8,CSNK1D,"Casein kinase 1, delta isoform 1", 17q25.3,29332
4.1,9,CSNK1E,Casein kinase 1 epsilon, 22q13.1,25461
4.1,10,PER1,Period 1, 17p13.1,11913
4.1,11,PER2,Period 2, 2q37.3,44407
4.1,12,PER3,Period 3, 1p36.23,60475
4.1,13,TIMELESS,Timeless (Drosophila) homolog, 12q13.3,32260
4.1,14,DBP,D site of albumin promoter (albumin D-box), 19q13.33,6642
4.1,15,NR1D1,"Nuclear receptor subfamily 1, group D, member 1 Rev-ErbAalpha", 17q21.1,7933
4.2,1,PROK2,Prokineticin 2 PK2 Clock output, 3p13,13406
4.2,2,GPR73L1,G-protein-coupled receptor 73-like 1 PKR2 Clock output, 20p12.3,12330
4.2,3,TGFA,Transforming growth factor alpha Clock output, 2p13.3,106512
4.2,4,EGFR,ERBB1 Clock outpu,t 7p11.2,137918
4.2,5,AANAT,Arylalkylamine N-acetyltransferase Clock output Melatonin, 17q25.1,2549
4.2,6,MTNR1A,Melatonin receptor 1A Clock output Melatonin, 4q35.2,22675
4.2,7,MTNR1B,Melatonin receptor 1B Clock output Melatonin, 11q14.3,13160
4.2,8,CRX,Cone rod homeobox Photoreception, 19q13.33,5524
4.2,9,OPN4,Opsin4 Melanopsin Photoreception, 10q23.2,11815
4.2,10,ADCYAP1,Adenylate cyclase-activating polypeptide PACAP Photoreception, 18p11.32,5664
4.2,11,ADCYAP1R1,Type I adenylate cyclase-activating polypeptide receptor Photoreception, 7p14.3,43503
4.2,12,FYN,Protein-tyrosine kinase fyn, 6q21,212143
4.2,13,GDI1,GDP dissociation inhibitor 1, Xq28,6293
4.2,14,RAB3A,"RAB3A, member RAS oncogene family", 19p13.11,7230
4.2,15,NPAS2,Neuronal PAS domain protein 2, 2q11.2,175551
5.1,1,PARK2,"Parkinson disease (autosomal recessive, juvenile) 2, parkin PARK2; PARKIN", 6q26 1,379130
5.1,2,SNCA,"Synuclein, alpha PARK1", 4q22.1, 111 429
5.1,3,PNUTL1,Peanut-like 1 CDCREL1, 22q11.21,8818
5.1,4,SNCAIP,Synuclein alpha-interacting protein Synphilin1, 5q23.2,151817
5.1,5,UCHL1,Ubiquitin carboxyl-terminal esterase L1 PARK5, 4p13,11518
5.1,6,GPR37,G-protein-coupled receptor 37 PAELR, 7q31.33,19566
5.1,7,UBB,Ubiquitin B precursor, 17p11.2,1688
5.1,8,UBE1,Ubiquitin-activating enzyme E1, Xp11.3,24267
5.1,9,STUB1,STIP1 homology and U-box containing protein 1 CHIP, 16p13.3,2277
5.1,10,UBE2L3,Ubiquitin-conjugating enzyme E2L 3 UBCH7, 22q11.21,56367
5.1,11,UBE2L6,Biquitin-conjugating enzyme E2L 6 UBCH8, 11q12.1,16325
5.1,12,PARK7,"Parkinson disease (autosomal recessive, early onset) 7 (PARK7) DJ1", 1p36.23,23544
5.2,1,RELN,Reelin Cell migration, 7q22.1,517727
5.2,2,DISC1,Disrupted in schizophrenia 1 Cell migration, 1q42.2,399739
5.2,3,NDEL1,nudE nuclear distribution gene E homolog like 1; Cell migration; NUDEL, 17p13.1,32293
5.2,4,PAFAH1B1,"Platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45 kDa LIS1 Cell migration", 17p13.3,91953
5.2,5,PTAFR,Platelet-activating factor receptor Cell migration, 1p35.3,27328
5.2,6,CHL1,Cell adhesion molecule with homology to L1CAM Cell migration, 3p26.3,212449
5.2,7,L1CAM,L1 cell adhesion molecule isoform 1 precursor Cell migration, Xq28,13925
5.2,8,NCAM1,Nerural cell adhesion molecule Cell migration, 11q23.1,314048
5.2,9,DTNBP1,Dysbindin1 Schizophrenia gene, 6p22.3,140167
5.2,10,NRG1,Neuregulin1 Schizophrenia gene, 8p12 1,103459
5.2,11,PRODH,Prolin dehydrogenase (oxidase) 1 Schizophrenia gene, 22q11,23771
5.2,12,CLDN11,Oligodendrocyte transmembrane protein Myelination, 3q26.2,13827
5.2,13,ERBB3,v-Erb-b2 erythroblastic leukemia viral oncogene Myelination, 12q13.2,22605
5.2,14,GALC,Galactosylceramidase precursor Myelination, 14q31.3,60484
5.2,15,MBP,Myelin basic protein Myelination, 18q23,37252
5.2,16,MOG,Myelin oligodendrocyte glycoprotein Myelination, 6p22.1,15621
5.2,17,OLIG1,Oligodendrocyte transcription factor 1 Myelination, 21q22.11,2276
5.2,18,OLIG2,Oligodendrocyte lineage transcription factor 2 Myelination, 21q22.11,3209
5.2,19,PLP1,Proteolipid protein 1 Myelination, Xq22.2,15706
5.2,20,SOX10,SRY (sex determining region Y)-box 10 Myelination, 22q13.1,12220
5.2,21,TF,Transferrin Myelination, 3q22.1,32401